Medicare Program Narrows Racial Disparities in Readmissions

Share this content:
Medicare Program Narrows Racial Disparities in Readmissions
Medicare Program Narrows Racial Disparities in Readmissions

WEDNESDAY, April 4, 2018 (HealthDay News) -- Medicare's Hospital Readmissions Reduction Program is associated with a narrowing of racial disparities in hospital readmissions, according to a study published in the April issue of Health Affairs.

José F. Figueroa, M.D., M.P.H., from Harvard University in Boston, and colleagues compared trends in 30-day readmission rates for congestive heart failure, acute myocardial infarction, and pneumonia among non-Hispanic whites versus non-Hispanic blacks, and among minority-serving hospitals versus others.

The researchers found that during the penalty-free implementation period (April 2010 to September 2012), readmission rates improved over the pre-implementation period (January 2007 to March 2010) for both whites and blacks. Over the study period, there was a significantly greater decline among blacks than among whites. However, after penalties began, readmission improvements slowed for both races. Similarly, minority-serving hospitals saw greater reductions in readmissions than other hospitals.

"Despite the narrowing of the two race-based gaps after announcement of the Hospital Readmissions Reduction Program, both persist," the authors write. "It remains to be seen whether new policy efforts will narrow these gaps and reduce the disproportionately high penalties that minority-serving hospitals face."

Abstract/ Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

CDC: Increase Seen in Salmonella Illnesses From Ground Beef

CDC: Increase Seen in <i>Salmonella</i> Illnesses From Ground ...

246 people now sickened; 59 people have been hospitalized; no deaths reported to date

Epinephrine Personal Autoinjectors Cost-Effective at 24

Epinephrine Personal Autoinjectors Cost-Effective at &#36;24

Based on 10-fold fatality risk difference, value-based price for personal epinephrine $24

Burden of Liver Cancer Rising in Medicare Patients

Burden of Liver Cancer Rising in Medicare Patients

Coexistence of other liver conditions tied to even higher risk for death, health care costs

is free, fast, and customized just for you!




Already a member?

Sign In Now »